Welcome to LookChem.com Sign In|Join Free
  • or
5-bromopyridine-2-carboxylic acid benzyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

188052-14-4

Post Buying Request

188052-14-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

188052-14-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 188052-14-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,0,5 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 188052-14:
(8*1)+(7*8)+(6*8)+(5*0)+(4*5)+(3*2)+(2*1)+(1*4)=144
144 % 10 = 4
So 188052-14-4 is a valid CAS Registry Number.

188052-14-4Relevant academic research and scientific papers

Regiospecific carboalkoxylation of 2,5-dibromopyridine

Chambers,Marfat

, p. 515 - 520 (1997)

Carboalkoxylation of 2,5-dibromopyridine with carbon monoxide and an alcohol in the presence of palladium acetate and 1,1'-bis(diphenylphosphino)ferrocene (dppf) occurs regiospecifically to afford esters of 5-bromo-pyridine-2-carboxylic acid in good yield.

Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use

-

Paragraph 0567, (2015/11/16)

In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R1, R2, R3, R4, R5, R9, ring A, ring B, m, n, p, -L1-, -L2-, and -L3- is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (“Aβ”) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimer's disease, are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 188052-14-4